Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Interim Management Statement

3 Nov 2008 07:00

RNS Number : 2276H
Tarsus Group PLC
03 November 2008
 

Tarsus Group plc

3 November 2008

Tarsus Group plc 

Interim Management Statement

Resilient performance, in line with management expectations

Tarsus ('Tarsus' or 'the Group') is today publishing its Interim Management Statement relating to the period from the publication of its interim results on 31 July 2008 to 31 October 2008.

Trading performance

Performance through the period has been in line with management's expectations.  We are encouraged by the resilience being demonstrated by our international portfolio of brand leader events. The key features of the period were as follows.

August

Off-Price Show (US): produced profits a little ahead of our expectations and the comparable show in 2007, despite like-for-like revenues being 4% lower. 

This was achieved through a combination of cost control and favourable currency movements. Bookings for the February 2009 event are tracking in line with comparable figures for the February 2008 show.

September 

The September events performed very well and overall produced results ahead of our expectations. 

1. Labelexpo Americas (US): the Group's biggest event of the year, produced like-for-like revenue growth of 8%.  It was well attended and exhibitors enjoyed strong levels of business interest.  Rebookings at this early stage stand at 80% for the event in 2010, thereby providing Tarsus with a high level of visibility

2. Modamont (clothing accessories) (France): produced revenue growth of 5%, in line with our expectations. 

3. Anti-Ageing (Germany): the first European edition of this event took place in Düsseldorf and encouragingly, for a first time event, was profitable. 

October

IP Convergence Show (Paris): France's largest IT event produced like-for-like revenue growth of 8%.

Business Development

The Group is continuing to develop its emerging market portfolio of events and refocus resources towards faster growth markets.

The strategy has been to minimise risk to the Group by replicating our established exhibition brands into these new higher growth markets. Key business developments in the period were as follows:

1. Anti-Ageing (South America): we are launching the first event in Sao Paolo which is scheduled to take place in June 2009. 

2. Aviation (China): the Group, through its joint venture with World Expo Shanghai Modern Group, has recently signed a memorandum of understanding to hold a new aviation event as part of the Government owned China International Industrial Fair. The launch exhibition is planned to take place annually in Shanghai starting in November 2009.

In line with this strategy, we have also continued to review our existing portfolio of events to ensure that the Group is best positioned to generate strong returns for its shareholders. During the period we disposed of our small European employment event, Employment Week, held annually in Brussels, for a small book profit.

Finance

The Group put its bank facilities out to competitive tender and has entered into new facilities, at competitive rates, to 30 September 2011. 

The period saw the Group generate strong cash flows. The very significant strengthening of the US dollar in the past month has seen our sterling translated net debt remain steady. The Group's debt is currently split into US dollars, Euros and Sterling

Change of Domicile

Tarsus recently announced proposals to introduce a new holding company into the Group structure. This company will be UK-listed, incorporated in Jersey and be tax resident in the Republic of Ireland

The change in domicile, which will be implemented by way of a Scheme of Arrangement, is expected to have a positive impact on the earnings per share of Tarsus in the medium term. The change of domicile was approved by Tarsus shareholders on 31 October 2008 and the process is expected to be complete by early December this year.

Board

The Group is today pleased to announce the appointment of Ashley Milton as Group Finance Director and this is covered in a separate announcement.

We announced on 3 October that Virginia Kern would be stepping down from the main Board to focus all her time and attention on our Dubai based business rather than on administrative matters associated with the change in domicile.

Outlook

Contracted revenues currently stand at 90% of our internal projections for the full year. This compares with 85% at the same time in 2007 and illustrates the resilience of the Group's products and the importance to our customers of direct sales channels such as exhibitions and the internet. 

Trading highlights for the Group for the remainder of 2008 include:

The business aviation show (MEBA) in Dubai later this month is expected to produce a strong result;

The first edition under our ownership of the India Label Show in Delhi in early December is expected to do likewise;

Bookings for the Anti-Ageing event in Las Vegas in mid-December are also currently tracking well ahead of the same period last year. However, we are about to enter the important last 6 week sales period for this event and we will have better visibility closer to its opening.

As we stated in the interim results, owing to its reliance on third and fourth quarter trading and a later booking cycle, we had factored cautious estimates into our full year sales projections for France The two events in November - Heavent and Educatec - are expected to produce revenues lower than last year.  In anticipation of these more difficult trading conditions in Franceour excellent French management team has already taken action over the past 12 months to significantly reduce their head count.  The French division continues to actively manage its cost base. 

The Group's key brands are continuing to perform well and bookings for our large 2009 biennial exhibitions are strong.  

Labelexpo returns to Europe in 2009 and space equivalent to the 2007 edition has already been contracted; 

In Dubai the next edition of the Air show takes place in November. Demand remains extremely strong and well ahead of the last show cycle. 

We are very pleased by the resilience being demonstrated by our international portfolio of brand leader events and our lack of dependence on the UK exhibitions market. 

Our reliance on US dollar and Euro revenues will cushion us from an increasingly challenging business climate but we anticipate further progress over the 2008/2009 cycle.

Tarsus Group plc:

Douglas Emslie, Group Managing Director 020 8846 2700

Media:

Matthew Moth, Madano Partnership 020 7593 4000

Investors/Analysts:

Neville Harris, IRfocus 020 7593 4015

Stephen Scott, Scott Harris 020 7653 0030

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSILFERIDLLVIT
Date   Source Headline
16th May 20197:00 amRNSTrading Update
9th May 20196:19 pmRNSBlock Listing Six Monthly Return
30th Apr 201910:14 amRNSTotal Voting Rights
16th Apr 20192:40 pmRNSDirector/PDMR Shareholding
2nd Apr 20193:43 pmRNSBlock listing Interim Review
1st Apr 201910:44 amRNSTotal Voting Rights
19th Mar 201911:42 amRNS2018 Annual Report
8th Mar 20194:36 pmRNSPrice Monitoring Extension
27th Feb 20197:00 amRNSFinal Results
6th Feb 20194:35 pmRNSPrice Monitoring Extension
31st Jan 201911:53 amRNSTotal Voting Rights
30th Jan 20197:00 amRNSOption agreement re Tarsus Connect
16th Jan 20194:22 pmRNSApplication for Admission
14th Jan 20197:00 amRNSYear-end Trading Update
13th Dec 20184:48 pmRNSScrip Dividend Circular (the "Circular")
30th Nov 20183:10 pmRNSTotal Voting Rights
20th Nov 20181:44 pmRNSApplication for Admission
6th Nov 20187:00 amRNSCapital Markets Seminar and Trading Update
1st Nov 20182:56 pmRNSTotal Voting Rights
18th Sep 20186:20 pmRNSDirector/PDMR Shareholding
14th Sep 201812:06 pmRNSResults of Placing
14th Sep 20187:00 amRNSAcquisitions and Placing of New Ordinary Shares
10th Sep 20183:18 pmRNSBlock Listing Six Monthly Return
31st Aug 20183:39 pmRNSTotal Voting Rights
24th Aug 201811:17 amRNSHalf-year Report
1st Aug 201811:54 amRNSTotal Voting Rights
26th Jul 20187:00 amRNSHalf-year Report
13th Jul 20182:34 pmRNSApplication for Admission - scrip dividend shares
13th Jul 20182:18 pmRNSDirector Declaration
21st Jun 20181:52 pmRNSResult of AGM
18th Jun 20183:37 pmRNSHolding(s) in Company
12th Jun 20184:41 pmRNSDirector/PDMR Shareholding
8th Jun 20183:45 pmRNSScrip Dividend Circular
1st Jun 201812:31 pmRNSTotal Voting Rights
21st May 20186:10 pmRNSNotice of AGM
17th May 20187:00 amRNSTrading Update
9th May 20187:00 amRNSBoard Changes
9th May 20187:00 amRNSBlock Listing Six Monthly Return
1st May 201811:45 amRNSTotal Voting Rights and Capital
20th Apr 201812:15 pmRNSDirector/PDMR Shareholding
20th Apr 201812:14 pmRNSDirector/PDMR Shareholding
18th Apr 20184:29 pmRNSNotification of Transactions
29th Mar 201810:50 amRNSTotal Voting Rights
22nd Mar 20185:01 pmRNS2017 Annual Report
9th Mar 20183:54 pmRNSDirector/PDMR Shareholding
6th Mar 201810:18 amRNSBlock Listing Six Monthly Return
5th Mar 20185:06 pmRNSDirector/PDMR Shareholding
28th Feb 20187:00 amRNSFinal Results
31st Jan 20189:40 amRNSTotal Voting Rights
12th Jan 201810:30 amRNSApplication for Admission - scrip dividend shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.